Erosive Esophagitis: Developing Drugs for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 17, 2025
September 16, 2025
985e94e3-4616-49e9-822e-0854256bb10e
Related Documents
Erosive Esophagitis: Developing Drugs for Treatment: Draft Guidance for Industry
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for Treatment: Draft Guidance for Industry
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Disseminated Coccidioidomycosis: Developing Drugs for Treatment
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.